Sarah Newey
@sneweyy.bsky.social
Global health security correspondent @telglobalhealth.bsky.social, based in Bangkok, formerly London.
Contact me: sarah.newey@telegraph.co.uk. Or find me elsewhere - @sneweyy
My work: https://sneweyy.squarespace.com/ / https://linktr.ee/neweysnews
Contact me: sarah.newey@telegraph.co.uk. Or find me elsewhere - @sneweyy
My work: https://sneweyy.squarespace.com/ / https://linktr.ee/neweysnews
Reposted by Sarah Newey
(2/5) Why? Because technicians can pivot rapidly from one vaccine technology or disease target to another – whether that’s research into a next-generation Ebola vaccine, or responding to a new pandemic threat
September 24, 2025 at 7:27 AM
(2/5) Why? Because technicians can pivot rapidly from one vaccine technology or disease target to another – whether that’s research into a next-generation Ebola vaccine, or responding to a new pandemic threat
“There has been no collective collapse of willpower in the world,” Dr Harriet Torlesse, a nutrition specialist at Unicef and lead author of the report, told @telglobalhealth.bsky.social. “What has changed? The industry. We’re surrounded by unhealthy food environments.”
September 10, 2025 at 2:21 AM
“There has been no collective collapse of willpower in the world,” Dr Harriet Torlesse, a nutrition specialist at Unicef and lead author of the report, told @telglobalhealth.bsky.social. “What has changed? The industry. We’re surrounded by unhealthy food environments.”